ADVAIR HFA 45-21 MCG INHALER

fluticasone propionate and salmeterol xinafoate
$19.9764per GM

Strength

45; 21 ug/1; ug/1

NDC

00173071520

Classification

Brand

Dosage Form

AEROSOL, METERED

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021254

On Market Since

9/29/2008

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.2%

3Y

-23.7%

5Y

-23.6%

All

+15.5%